OVERVIEW
The global market size for in-vitro diagnostics is expected to reach USD 88.23 billion by 2024, growing over the forecast period at a CAGR of 5.1%. The rising demand for early and accurate diagnosis of disease, increasing infectious disease prevalence, increasing the adoption of fully automated tools and automation in laboratories, and increasing awareness of personalized medicine are key drivers of market growth.
TABLE OF CONTENT
1 Global In Vitro Diagnosis Quality Controls MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global In Vitro Diagnosis Quality Controls Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global In Vitro Diagnosis Quality Controls Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global In Vitro Diagnosis Quality Controls Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global In Vitro Diagnosis Quality Controls Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global In Vitro Diagnosis Quality Controls Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global In Vitro Diagnosis Quality Controls Market – By Type (Market Size – & million/billion)
8.1 Quality Control Products
8.2 Data Management Solutions
8.3 Quality Assurance Services
9 Global In Vitro Diagnosis Quality Controls Market – By Application
9.1 Immunochemistry/Immunoassay
9.2 Clinical Chemistry
9.3 Hematology
9.4 Molecular Diagnostics
9.5 Coagulation & Hemostasis
9.6 Others
10 Global In Vitro Diagnosis Quality Controls Market – By Manufacturer Type
10.1 Instrument Manufacturer Control
10.2 Independent Manufacturer Control
11 Global In Vitro Diagnosis Quality Controls Market – By End User
11.1 Hospitals
11.2 Clinical Laboratories
11.3 Academic & Research Institutes
12 Global In Vitro Diagnosis Quality Controls Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global In Vitro Diagnosis Quality Controls Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global In Vitro Diagnosis Quality Controls Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Bio-Rad Laboratories, Inc.
14.3 Thermo Fisher Scientific, Inc.
14.4 Helena Laboratories
14.5 Roche Diagnostics
14.6 Abbott Laboratories Inc.
14.7 Sero AS
14.8 Sun Diagnostics, LLC
14.9 Seracare Life Sciences, Inc.
14.10 Randox Laboratories Ltd.
14.11 Siemens AG
14.12 Company 11 & more
15 Global In Vitro Diagnosis Quality Controls Market – Appendix
15.1 Sources
15.2 Abbreviations